Loading...
415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
BACKGROUND: Isavuconazole (ISA) is a novel triazole antifungal approved for treating invasive aspergillosis and mucormycosis. While ISA is increasingly used for prophylaxis in hematologic malignancy patients when other azoles are contraindicated, there are currently limited data on breakthrough inva...
Saved in:
| Published in: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6253539/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|